abstract |
(57) [Summary]nA liposome-encapsulated camptothecin formulation is provided. These liposomes have improved pharmacokinetics, enhanced potency as an antitumor agent, and provide an increased therapeutic index compared to free drug and topotecan. These formulations include liposomes containing at least one phospholipid and camptothecin or an analog thereof. |